These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 16718772)
1. Analysis of variabilities of serum proteomic spectra in patients with gastric cancer before and after operation. Ren H; Du N; Liu G; Hu HT; Tian W; Deng ZP; Shi JS World J Gastroenterol; 2006 May; 12(17):2789-92. PubMed ID: 16718772 [TBL] [Abstract][Full Text] [Related]
2. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer. Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528 [TBL] [Abstract][Full Text] [Related]
3. [Screen and identification of serum protein biomarkers in gastric cancer]. Zhang H; Li H; Guo F; Zhang D; Yang H; Wang J Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Mar; 19(3):317-22. PubMed ID: 27003656 [TBL] [Abstract][Full Text] [Related]
4. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry. Liu XP; Shen J; Li ZF; Yan L; Gu J Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557 [TBL] [Abstract][Full Text] [Related]
5. [Protein profiles of serum in gastric cancer at a high-risk area by SELDI-TOF mass spectrometry]. Wang YS; Shen J; Yu JK; Zhang L; Ma JL; You WC; Pan KF Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Sep; 42(9):677-80. PubMed ID: 19175180 [TBL] [Abstract][Full Text] [Related]
6. Identification of gastric cancer patients by serum protein profiling. Ebert MP; Meuer J; Wiemer JC; Schulz HU; Reymond MA; Traugott U; Malfertheiner P; Röcken C J Proteome Res; 2004; 3(6):1261-6. PubMed ID: 15595736 [TBL] [Abstract][Full Text] [Related]
7. Application of serum SELDI proteomic patterns in diagnosis of lung cancer. Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516 [TBL] [Abstract][Full Text] [Related]
8. Serum diagnosis of diffuse large B-cell lymphomas and further identification of response to therapy using SELDI-TOF-MS and tree analysis patterning. Zhang X; Wang B; Zhang XS; Li ZM; Guan ZZ; Jiang WQ BMC Cancer; 2007 Dec; 7():235. PubMed ID: 18163913 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic application of serum proteomic patterns in gastric cancer patients by ProteinChip surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Lim JY; Cho JY; Paik YH; Chang YS; Kim HG Int J Biol Markers; 2007; 22(4):281-6. PubMed ID: 18161659 [TBL] [Abstract][Full Text] [Related]
10. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry]. Zhang GQ; Du J; Pang D Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606 [TBL] [Abstract][Full Text] [Related]
11. Proteomics-based identification of a tumor-associated antigen and its corresponding autoantibody in gastric cancer. Tsunemi S; Nakanishi T; Fujita Y; Bouras G; Miyamoto Y; Miyamoto A; Nomura E; Takubo T; Tanigawa N Oncol Rep; 2010 Apr; 23(4):949-56. PubMed ID: 20204278 [TBL] [Abstract][Full Text] [Related]
12. Identification of macrophage migration inhibitory factor and human neutrophil peptides 1-3 as potential biomarkers for gastric cancer. Mohri Y; Mohri T; Wei W; Qi YJ; Martin A; Miki C; Kusunoki M; Ward DG; Johnson PJ Br J Cancer; 2009 Jul; 101(2):295-302. PubMed ID: 19550422 [TBL] [Abstract][Full Text] [Related]
13. Proteomic biomarker predicts therapeutical effects of oxaliplatin combining with fluoropyrimidine in metastatic gastric cancer patients by the SELDI-proteinchip platform. Yu Z; Yu JK; Fang XF; Yuan Y; Shen H Hepatogastroenterology; 2013 Oct; 60(127):1800-4. PubMed ID: 24624447 [TBL] [Abstract][Full Text] [Related]
14. The proteomics approach to find biomarkers in gastric cancer. Ryu JW; Kim HJ; Lee YS; Myong NH; Hwang CH; Lee GS; Yom HC J Korean Med Sci; 2003 Aug; 18(4):505-9. PubMed ID: 12923326 [TBL] [Abstract][Full Text] [Related]
15. Mining novel biomarkers for prognosis of gastric cancer with serum proteomics. Qiu FM; Yu JK; Chen YD; Jin QF; Sui MH; Huang J J Exp Clin Cancer Res; 2009 Sep; 28(1):126. PubMed ID: 19740432 [TBL] [Abstract][Full Text] [Related]
16. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596 [TBL] [Abstract][Full Text] [Related]
17. High-resolution serum proteomic features for ovarian cancer detection. Conrads TP; Fusaro VA; Ross S; Johann D; Rajapakse V; Hitt BA; Steinberg SM; Kohn EC; Fishman DA; Whitely G; Barrett JC; Liotta LA; Petricoin EF; Veenstra TD Endocr Relat Cancer; 2004 Jun; 11(2):163-78. PubMed ID: 15163296 [TBL] [Abstract][Full Text] [Related]
18. SELDI-TOF serum proteomics and colorectal cancer: a current overview. Gemoll T; Roblick UJ; Auer G; Jörnvall H; Habermann JK Arch Physiol Biochem; 2010; 116(4-5):188-96. PubMed ID: 20615064 [TBL] [Abstract][Full Text] [Related]
19. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics. Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929 [TBL] [Abstract][Full Text] [Related]
20. Serum proteomic patterns for gastric lesions as revealed by SELDI mass spectrometry. Liang Y; Fang M; Li J; Liu CB; Rudd JA; Kung HF; Yew DT Exp Mol Pathol; 2006 Oct; 81(2):176-80. PubMed ID: 16828742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]